Improving the drug development process by reducing the impact of adverse events: The case of cataracts considered

Andrew F. Smith, Alexander Klotz, I. Michael Wormstone

Research output: Journal PublicationReview articlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Improving the drug development process by reducing the impact of adverse events: The case of cataracts considered'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science